Semaglutida, a peptide drug approved by the FDA to treat type 2 Diabetes y obesidad, achieves weight loss by acting on GLP-1 receptors to control appetite. En resumen, Semaglutide allows you to reduce your food intake without feeling hungry, thus promoting weight loss. If you do not feel appetite suppression after using Semaglutide, you are still gaining weight, Qué es …